Fulcrum Therapeutics (FULC) Stock Chart & Stock Price History $3.66 +0.02 (+0.41%) As of 01:14 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Fulcrum Therapeutics Stock Price Performance The Fulcrum Therapeutics (FULC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 62.12%, with a year-to-date return of -67.68%. In the past month, the stock has decreased 2.27%, reflecting recent market activity. As of the latest close, Fulcrum Therapeutics traded at $3.64 with a market cap of $277.73 million and volume of 773,326 shares. Five years ago, the stock traded at $23.23, representing a 84.27% decrease over that period. At the time, it had a market cap of $0.00 and a volume of 338,750 shares. Receive FULC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fulcrum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.68%1 Month Performance-2.27%3 Month Performance-2.01%Year-To-Date Performance-67.68%1 Year Performance-62.12%5 Year Performance-84.27% FULC Stock Chart for Tuesday, October, 27, 2026 FULC Chart by TradingView Fulcrum Therapeutics Stock Price History Daily Weekly Monthly Yearly Interval 9/27/2026 - 10/27/2026 Price Date Price Date From Price Date To 1M3M6MYTD1Y3Y5Y More filters Fewer filters Done 0 Results Export DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/26/2026$3.68$3.64-1.09%$3.69$3.63773,326 shs$277.73 million10/23/2026$3.68$3.68$3.69$3.641.07 million shs$280.78 million10/22/2026$3.70$3.68-0.54%$3.74$3.662.31 million shs$280.78 million10/21/2026$3.72$3.70-0.54%$3.75$3.70923,780 shs$282.30 million10/20/2026$3.70$3.72+0.54%$3.75$3.70757,122 shs$283.84 million10/19/2026$3.65$3.70+1.37%$3.72$3.661.19 million shs$282.31 million10/16/2026$3.67$3.65-0.54%$3.69$3.641.39 million shs$278.50 million10/15/2026$3.67$3.67$3.73$3.661.23 million shs$280.01 million10/14/2026$3.68$3.67-0.27%$3.72$3.651.66 million shs$280.02 million10/13/2026$3.75$3.68-1.87%$3.75$3.681.46 million shs$280.78 million Get the Latest News and Ratings for FULC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fulcrum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/12/2026$3.77$3.75-0.53%$3.77$3.731.61 million shs$286.11 million10/09/2026$3.75$3.77+0.53%$3.79$3.721.80 million shs$287.64 million10/08/2026$3.67$3.75+2.18%$3.78$3.662.63 million shs$286.13 million10/07/2026$3.69$3.67-0.54%$3.72$3.671.04 million shs$280.02 million10/06/2026$3.71$3.69-0.54%$3.73$3.68756,834 shs$281.54 million10/05/2026$3.69$3.71+0.54%$3.73$3.681.06 million shs$283.07 million10/02/2026$3.68$3.69+0.27%$3.76$3.651.54 million shs$281.55 million10/01/2026$3.70$3.68-0.41%$3.72$3.671.23 million shs$280.78 million09/30/2026$3.70$3.70-0.14%$3.73$3.671.92 million shs$281.92 million09/29/2026$3.72$3.70-0.54%$3.79$3.691.84 million shs$282.31 million09/28/2026$3.74$3.72-0.53%$3.76$3.71901,247 shs$283.84 million Related Companies VOR Stock Chart REPL Stock Chart JANX Stock Chart CVAC Stock Chart IMTX Stock Chart MNKD Stock Chart SVRA Stock Chart GLUE Stock Chart MGTX Stock Chart CGEM Stock Chart Receive FULC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fulcrum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:FULC) was last updated on 10/27/2026 by MarketBeat.com Staff. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredFirst Look: Elon’s “Starphone”Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulcrum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulcrum Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
